Return to study ST003050 main page

Download data matrix(Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets (Part 1/3 - Plasma and serum eicosadomics) Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODEDonor_1_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Plasma_after_Aspirin_1Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Plasma_after_Aspirin_2Sample material:Plasma | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Plasma_after_Omega3_1Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Plasma_after_Omega3_2Sample material:Plasma | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Plasma_before_Aspirin_1Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Plasma_before_Aspirin_2Sample material:Plasma | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Plasma_before_Omega3_1Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Plasma_before_Omega3_2Sample material:Plasma | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Serum_after_Aspirin_1Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Serum_after_Aspirin_2Sample material:Serum | Treatment:after_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Serum_after_Omega3_1Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Serum_after_Omega3_2Sample material:Serum | Treatment:after_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_1_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_2_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_3_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_4_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_5_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Serum_before_Aspirin_1Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_6_Serum_before_Aspirin_2Sample material:Serum | Treatment:before_Aspirinnormalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_10_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_11_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_12_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_7_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_8_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Serum_before_Omega3_1Sample material:Serum | Treatment:before_Omega3normalized AUC
Reversed phase NEGATIVE ION MODEDonor_9_Serum_before_Omega3_2Sample material:Serum | Treatment:before_Omega3normalized AUC
  logo